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Abstract We herein present a preliminary practical algo-
rithm for evaluating complementary and alternative med-
icine (CAM) for children which relies on basic bioethical
principles and considers the influence of CAM on global
child healthcare. CAM is currently involved in almost all
sectors of pediatric care and frequently represents a
challenge to the pediatrician. The aim of this article is to
provide a decision-making tool to assist the physician,
especially as it remains difficult to keep up-to-date with the
latest developments in the field. The reasonable application
of our algorithm together with common sense should
enable the pediatrician to decide whether pediatric (P)-
CAM represents potential harm to the patient, and allow
ethically sound counseling. In conclusion, we propose a
pragmatic algorithm designed to evaluate P-CAM, briefly
explain the underlying rationale and give a concrete clinical
example.
Keywords Algorithm . Alternative . Complementary .
Pediatric
Abbreviations CAM: Complementary and alternative
Medicine . CAN: Child abuse and neglect .
CME: Continuing medical education . p-CAM:
Pediatric complementary and alternative medicine
Introduction
Complementary and alternative medicine (CAM) is used in
the prevention of, but also as therapy for, acute [2, 15] and
chronic diseases in children [14, 16] and has recently been
integrated into the research agendas of pediatric academic
societies as a priority [3]. Recent surveys indicate that up to
50% of patients requiring in- or out-patient care in a
European hospital use CAM [18], but these approaches are
often not openly discussed with healthcare teams [5].
Because of the significant number of different approaches
and perspectives, and abundance of information of varying
quality, CAM therapies frequently represent a challenge to
the office pediatrician [9, 10, 17]. Medical school curricula
and post-graduate continuing medical education (CME)
programs have only recently introduced teaching programs
that include decision-making in the area of pediatric CAM
(p-CAM) [4]. On the front-line, pediatricians often face
misinformed/uninformed parents, who rely on sources of
information (family, friends or the internet) who may be
unaware of potential risks [12, 13].
Attempts have been made to provide the practitioner
with reproducible and valuable scientific data on “main-
stream” p-CAM, such as acupuncture, homeopathy and
herbal remedies, but many therapies remain uninvestigated
[1]. Furthermore, some experts suggest that some p-CAM
therapies may not be amenable to the usual scientific
evaluation process. Other authors discuss liability issues,
medical misconduct and malpractice that p-CAM could
imply [4]. Unfortunately, very few authors offer pragmatic
decision-making strategies that could help the pediatrician
and the patient.
As it remains difficult to keep up-to-date with the latest
developments in this field, and only a few well-designed
studies clearly attest to the benefits of CAM, we propose
here a pragmatic algorithm designed to evaluate CAM in
the pediatric setting.
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Building the algorithm
With the aim of offering a practical decision-making
strategy, we reviewed the existing literature and observed
common trends and views that we used to establish an
algorithm applicable to any patient and therapy. Unfortu-
nately, our search of the literature did not retrieve any
previous attempt to establish a similar decision-making
tool which could provide the pediatrician with a clearer
overview of types of therapies his patient may desire to
embark on. The attention of the community, however,
seems to be focused on describing the position of the
pediatric patient and his family within the context of p-
CAM [6] and on the potential legal consequences of p-
CAM application in children (liability and malpractice
concerns). An office-based pediatrician can hardly keep
up-to-date with the integrality of the most recent literature
in this field and thus should be provided with practical tools
for decision-making. The healthcare management commu-
nity has already adopted this pragmatic attitude [16].
Furthermore, we also took into account the fact that, in
most countries, pediatricians are required to declare
potential situations of childhood abuse and neglect.
When observing behavior in his practice that might point
towards abuse or neglect, the pediatrician might be
required by law to refer the situation to the competent
judiciary instances, depending on national or local
legislation. This compulsory declaration may place the
physician in a conflicting position with regards to his
patient. A valuable attitude in these moments is, in our
opinion, to apply common sense with the aim of never
interrupting the lines of communication with the patient
and his family.
The bioethical principles
All decisions that keep in mind the four basic principles of
bioethics (autonomy, beneficence, nonmaleficence and
justice) can generally be considered to be correct and
defendable in the face of professional and legal authorities,
especially when common sense is applied [7]. Even if we
consciously oversimplify the philosophical underpinnings,
these principles allow us to establish two conceptual
dimensions by which to grade and evaluate the therapy of
concern, namely safety and efficacy. A simple diagram, as
presented in Fig. 1, can be drawn and used for an initial
impression [7]. All therapies, conventional or P-CAM, can
be inserted, thereby allowing a comprehensive picture of
the options, may they be ongoing or prospective. This
diagram has already been used extensively to measure the
risk of malpractice liability associated to CAM in adults
[8], and some authors have mentioned its potential in the
pediatric setting [4]. This conceptual diagram should
constitute the core of the algorithm.
In reality, only very few therapies can be classified into
the straightforward Encourage and Discourage zones of
the diagram, which represent de facto no decisional
dilemma. To simplify decision-making, we considered
that unsafe therapies should be discouraged, while safe
therapies could be tolerated even if ineffective, but only if
they do not interfere with or interrupt an ongoing effective
approach. Safe but ineffective therapy should be tolerated
as a complement, but not as exclusive strategy.
In our understanding, an unlimited quantity of clinical
examples would be necessary to illustrate and thoroughly
discuss these gray-zones defined by unsafe/effective and
safe/ineffective CAM therapies. Such in-depth analysis
overrides the scope of our article and algorithm, and we
believe in the necessity of leaving the pediatrician and the
patient maneuvering room for discussion and reflection
within the boundaries of the trust-based patient-physician
relationship.
The algorithm
Figure 2 summarizes our decision-making algorithm. We
have classified the above-mentioned conditional questions
into a logical order of priority.
Initial questions should assess situations from which the
child could be diverted or even induced to abandon a vital
ongoing therapy. In such cases, the pediatrician should
discourage proceeding to – or continuing – the CAM
therapy under discussion. Child abuse and neglect (CAN)
should in any such case be clearly discussed, excluded or
declared to legal authorities.
As a second priority, the pediatrician should verify if an
informed decision of the parents, and eventually of the
child, has been taken. Some questions that may be posed
are the following. How much do the parents know about
the therapeutic project? Have the parents (and the child)
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Fig. 1 Core “Safety-Efficacy” diagram based on bioethical prin-
ciples. This diagram is a simplified and modified version of the
liability risk analysis as presented by Cohen and Eisenberg [3].
Comment: In doubtful situations, we recommend grading the quality
of the discussed therapy as unsure or inefficacious. This cautious
attitude can be adopted, given that most common therapies in P-
CAM have not been studied in randomized controlled trials and,
consequently, evidence is not available to make an educated
decision; thus, common sense should prevail
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understood and measured potential risks and eventual
benefits? Have they weighed any potential social or
religious impact? What would the quality of life be for
the child and his/her family if a new p-CAM therapy is
started? Is there awareness of the associated economic
costs? We should never neglect any potential social and
economic implications. In fact, a safe and effective – but
expensive – treatment may represent possible economic
hardship to the family.
Only after having answered these two fundamental
questions, should the pediatrician evaluate safety and
efficacy as described in Fig. 1. In doubtful situations, when
either efficacy or safety are uncertain, the caregiver
may schedule a re-assessment of the situation and offer
follow-up.
We recommend verifying whether or not evidence, or a
reasonable consensus, supports the application of the
therapy and can be found in the scientific literature. It is an
absolute necessity that this crucial step of the algorithm be
discussed openly with the patient and his/her family and
that the discussion and conclusions (if any) subsequently
be recorded in the patient’s personal chart. Moreover, we
suggest that an update of information be obtained regularly.
If this is the case, a new p-CAM can be encouraged. If it is
not the case, we suggest tolerating the initiation of the new
p-CAM therapy and following the evolution of the child’s
health and his/her family’s situation with regular assess-
ments, informing the patient and his family of potential
hazards and socio-economical issues.
Application of the algorithm: case presentation
A 6-year-old girl known as having chronic childhood
asthma (in a context of familial atopy) and her parents
come to your general pediatric office. They explain their
intent to start an herbal oil massage therapy based on an
ancestral Alpine village tradition. They have heard of it
from a neighbor. They request your opinion about this idea.
The pediatrician’s point of view is that this idea may
have arisen from the frustrations felt by the child and the
family during the frequent acute episodes, which he has not
successfully prevented to date. Puzzled as to what to say,
and concerned not to allow a hazardous therapy to begin,
he decides to use the described algorithm to help him with
this situation.
Before applying the algorithm, he establishes a complete
recent history and obtains more details about the massage
therapy. It consists of sunflower oil in which herbs and
flowers, collected in the fields of a nearby Alpine region,
have been immersed for 3 years and stored in a cold and
humid cellar. The specifications of the types of herbs and
flowers are unknown to the family. The massage consists of
the direct application of this mix to small surfaces of the
face and the pectoral region once a day in the morning.
Step 1:
The pediatrician asks the parents about their feelings
on the actual standard and proven therapy he has
introduced. Will they stop giving the evidence-based
inhalations and the leukotriene antagonist (montelu-
kast) he has prescribed? Will they reduce the
recommended preventive inhalations? The parents
confirm their trust in the efficacy of the ongoing
therapy for the acute episodes and certainly will
continue with the preventive inhalations, but they
think it might not be enough to help their child. The girl
agrees and mentions her sadness, saying that the drugs
already used do not work well enough.
Step 2:
The pediatrician follows the algorithm and tries to
understand why the family thinks this new therapy
might help. They mention 20 children in the Alpine
village and surroundings who “have noticed an
improvement with their asthma after the massage
therapy started”. They also mention that they have read
on the internet that some mountain flowers have an
anti-asthmatic effect. They tell the physician that they
will go back to the Alpine village and ask the old lady
who prepares the oils for details. Both parents are
physicians themselves and clearly state they do not
know the exact mechanism of action of the massages,
but they think that trying it out will tell them if it helps
their daughter.
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Fig. 2 Decision-making algorithm
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Step 3:
The pediatrician returns to the algorithm and asks
about the price of the oil mixture. The parents say it
will cost 20 Euros per month, and state it will not be a
burden for the household budget. He enquires about
the potential effects of the new therapy on the child’s
life and on the family’s life. They say that the massage
will be performed by one of the parents for 10 min in
the morning before breakfast. The smell is said to be
pleasant.
Step 4:
The pediatrician continues with the algorithm and tells
the parents he has doubts on the efficacy of the
treatment. He suggests he will have a look in the
existing medical literature and asks for details about
the underlying rationale. The parents give him the
phone number of the old lady who prepares the oils. He
then asks about the potential risk that the oils used in
the massages might increase the skin problems in their
child? He explains his concerns that the massage might
burn the skin, induce irreversible lesions, increase her
atopic dermatitis or even cause infections. The parents
state that the 20 children treated had no such
complications, and that they will carefully screen for
any secondary effect.
In summary, the pediatrician’s impression is that he has
doubts about safety and efficacy of this therapy in this
atopic child. He discusses his concerns openly with the
family and reschedules an appointment after he has had
time to look for evidence or consensus on such therapy in
the literature and after having had more details on the
massage oil from the producer.
We believe that the rational application of our algorithm
allows the pediatrician to ask all of the essential questions
and to establish a plan on how to proceed with the situation.
In the case presented here, the pediatrician will be able to
obtain a clear picture of the new therapy, anticipate
potential risks for the child and establish a plan for follow-
up. Most importantly, he will achieve this by openly
discussing his concerns with the family, thus providing a
stimulus for the parents themselves to reflect on whether –
or not – to start this new approach in the hope of relieving
their daughter’s health issues.
The reality of actual patient-doctor communication
as a limitation
One major problem is the fact that patients and their parents
seem to consider discussing p-CAM therapies with
healthcare providers a taboo [5, 14, 18]. A recent review
of the literature on the topic highlights the importance of
offering patients and parents space within the therapeutic
relationship [11] and respecting a few simple rules. One of
these rules could be to remain open to the idea that there
may be different, equally interesting paths to a child’s good
health. We believe that the pediatric practitioner is
indispensable in improving the awareness of, and provid-
ing education on, p-CAM therapies and that by doing so he
may increase the ease at which the topic can be openly
discussed with patients and parents. We also hope that an
approach attempting to simplify and provide a practical
decision-making will contribute to the integration of
p-CAM in the pediatric routine.
Conclusion
In conclusion, we have established a pragmatic algorithm
for decision-making in p-CAM. The application of
bioethical principles added to basic pediatric fundamentals
can help the physician in dealing with this field and allow
debate between specialists and p-CAM therapists as to how
to integrate p-CAM in everyday clinical practice. The
reasonable application of our algorithm along with
common sense should enable the pediatrician both to
decide whether or not p-CAM is potentially harmful to the
patient and to provide ethically sound counseling.
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